Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Document › Details

Cellnovo. (7/7/17). "Press Release: Cellnovo Successfully Raises €17.5 Million from Healthcare Investors [Not for Distribution in the United States of America, Canada, Australia and Japan]".

Organisations Organisation Cellnovo Group S.A. (Euronext: CLNV)
  Group Cellnovo (Group)
  Group OTHER
Products Product Cellnovo Diabetes Management System
  Product 2 investment banking
Index term Index term Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors
Persons Person Baratte, Sophie (Cellnovo 201602 CEO)
  Person 2 Merigeau, Nicolas (NewCap 201502)

Record changed: 2023-06-05


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Cellnovo (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top